HKG:6821 Market Cap

HKG:6821 has a market cap or net worth of 42.14 billion as of August 15, 2025. Its market cap has increased by 65.92% in one year.

Market Cap

42.14B

Enterprise Value

33.98B

Revenue

6.38B

Ranking

n/a

PE Ratio

39.55

Stock Price

98.80

Market Cap Chart

Since November 18, 2016, HKG:6821's market cap has increased from 5.59B to 42.14B, an increase of 653.68%. That is a compound annual growth rate of 25.99%.

Market Cap History

Date	Market Cap	% Change
Aug 14, 2025	41.96B	50.28%
Dec 31, 2024	27.92B	-38.76%
Dec 29, 2023	45.59B	-23.48%
Dec 30, 2022	59.58B	-56.36%
Dec 31, 2021	136.53B	58.47%
Dec 31, 2020	86.15B	157.03%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeOne Medicines	265.60B
Hansoh Pharmaceutical Group Company	226.30B
JD Health International	179.05B
Innovent Biologics	162.71B
Akeso	141.46B
Sino Biopharmaceutical	137.89B
WuXi Biologics	125.37B
CSPC Pharmaceutical Group	119.48B

Market Cap Rankings